These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21558139)

  • 1. Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population.
    Doníz-Padilla L; Martínez-Jiménez V; Niño-Moreno P; Abud-Mendoza C; Hernández-Castro B; González-Amaro R; Layseca-Espinosa E; Baranda-Cándido L
    Lupus; 2011 May; 20(6):628-35. PubMed ID: 21558139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
    Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
    Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.
    Banica LM; Besliu AN; Pistol GC; Stavaru C; Vlad V; Predeteanu D; Ionescu R; Stefanescu M; Matache C
    Int J Rheum Dis; 2016 Dec; 19(12):1294-1303. PubMed ID: 25351606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
    Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
    Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradation.
    Li X; Sun W; Huang M; Gong L; Zhang X; Zhong L; Calderon V; Bian Z; He Y; Suh WK; Li Y; Song T; Zou Y; Lian ZX; Gu H
    Immunity; 2024 Jul; 57(7):1603-1617.e7. PubMed ID: 38761804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study of Interleukin-2 Production and Nck Adaptor Molecule Gene Expression in Systemic Lupus Erythematosus Patients.
    Towiwat P; Buttham B
    J Med Assoc Thai; 2017 Apr; 100(4):396-402. PubMed ID: 29911835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
    Kitaura Y; Jang IK; Wang Y; Han YC; Inazu T; Cadera EJ; Schlissel M; Hardy RR; Gu H
    Immunity; 2007 May; 26(5):567-78. PubMed ID: 17493844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.
    Stürner KH; Borgmeyer U; Schulze C; Pless O; Martin R
    J Immunol; 2014 Nov; 193(9):4439-47. PubMed ID: 25261476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.
    Bergholdt R; Taxvig C; Eising S; Nerup J; Pociot F
    J Leukoc Biol; 2005 Apr; 77(4):579-85. PubMed ID: 15629882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular alterations in the TCR signaling pathway in patients with aplastic anemia.
    Li B; Guo L; Zhang Y; Xiao Y; Wu M; Zhou L; Chen S; Yang L; Lu X; Li Y
    J Hematol Oncol; 2016 Mar; 9():32. PubMed ID: 27036622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis.
    Vazgiourakis VM; Zervou MI; Choulaki C; Bertsias G; Melissourgaki M; Yilmaz N; Sidiropoulos P; Plant D; Trouw LA; Toes RE; Kardassis D; Yavuz S; Boumpas DT; Goulielmos GN
    Ann Rheum Dis; 2011 Dec; 70(12):2184-90. PubMed ID: 21914625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity.
    Machado-Contreras JR; Muñoz-Valle JF; Cruz A; Salazar-Camarena DC; Marín-Rosales M; Palafox-Sánchez CA
    Clin Exp Med; 2016 Aug; 16(3):399-406. PubMed ID: 26013387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients.
    Lin YZ; Li RN; Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
    Autoimmunity; 2014 Feb; 47(1):23-6. PubMed ID: 24219225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients.
    Zhu L; Zhou L; Wang L; Li Z; Lu S; Yang L; Chen S; Li B; Wu X; Zhou Y; Li Y
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):409-414. PubMed ID: 27435953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis.
    Huang Q; Chen SS; Li J; Tao SS; Wang M; Leng RX; Pan HF; Ye DQ
    Ir J Med Sci; 2018 Feb; 187(1):243-249. PubMed ID: 28560518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell specific upregulation of Sema4A as risk factor for autoimmunity in systemic lupus erythematosus and rheumatoid arthritis.
    Cavalcanti CAJ; Germoglio V; de Azevêdo Silva J; Glesse N; Vianna P; Cechim G; Monticielo OA; Xavier RM; Brenol JCT; Brenol CV; Fragoso TS; Barbosa AD; Duarte ÂLBP; Oliveira RDR; Louzada-Júnior P; Donadi EA; Chies JAB; Crovella S; Sandrin-Garcia P
    Autoimmunity; 2020 Mar; 53(2):65-70. PubMed ID: 31876207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.
    Pistol G; Matache C; Calugaru A; Stavaru C; Tanaseanu S; Ionescu R; Dumitrache S; Stefanescu M
    J Cell Mol Med; 2007; 11(2):339-48. PubMed ID: 17488482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.
    Eggleton P; Harries LW; Alberigo G; Wordsworth P; Viner N; Haigh R; Donnelly S; Jones HW; Chikanza IC; O'Conner TW; Thomson AE; Winyard PG
    J Clin Immunol; 2010 Sep; 30(5):649-58. PubMed ID: 20532967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
    Rozo C; Chinenov Y; Maharaj RK; Gupta S; Leuenberger L; Kirou KA; Bykerk VP; Goodman SM; Salmon JE; Pernis AB
    Ann Rheum Dis; 2017 Apr; 76(4):740-747. PubMed ID: 28283529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.